Key result
Prosthesis-patient mismatch after aortic valve replacement was associated with a significantly higher risk of 30-day all-cause mortality compared to no mismatch (OR 16.493).
Why the study?
Does prosthesis-patient mismatch increase short-term mortality in patients undergoing aortic valve replacement?
Cohort (n=869)
No
Does prosthesis-patient mismatch increase short-term mortality in patients undergoing aortic valve replacement?
Odds Ratio: 16.493 (95% CI 2.306–117.95)
Absolute Event Rate: 2.1% vs 0.5%
p-value: p=0.005
Prosthesis-patient mismatch after aortic valve replacement is associated with significantly higher 30-day all-cause mortality in a Chinese cohort.
May prompt refined prosthesis selection in aortic valve replacement; leaves open causal confirmation in prospective studies.
BACKGROUND: Prosthesis-patient mismatch (PPM) may affect the clinical outcomes of patients undergoing aortic valve replacement (AVR). We aimed to determine the incidence of PPM, its effect on short-term mortality, and the factors contributing to PPM in China. METHODS: . The baseline, echocardiographic, operative, and outcome data of all patients were collected from the national database. RESULTS: A total of 869 patients were included in the study. PPM was detected in 15.9% (138/869) of the patients. Four patients (0.5%) met the criteria for severe PPM. Patients with PPM were older and had a higher prevalence of diabetes, coronary heart disease, aortic stenosis (AS), and preoperative left ventricular dysfunction but a lower incidence of smoking history and aortic regurgitation. Logistic regression analysis showed that female gender (P < 0.001), AS (P = 0.014), higher body mass index (BMI) (P < 0.001), and bioprosthesis (P < 0.001) were independent predictors of PPM. We also found that PPM (P = 0.005) was associated with 30-day all-cause mortality, along with smoking history (P = 0.001) and low preoperative left ventricular ejection fraction (LVEF) (P = 0.004). CONCLUSIONS: PPM is associated with high short-term mortality after AVR in China. Female gender, aortic stenosis, bioprosthesis, and high BMI are risk factors for the incidence of PPM.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2017) conducted a cohort in Aortic valve replacement (n=869). Prosthesis-patient mismatch vs. No prosthesis-patient mismatch was evaluated on 30-day all-cause mortality (OR 16.493, 95% CI 2.306-117.950, p=0.005). Prosthesis-patient mismatch after aortic valve replacement was associated with a significantly higher risk of 30-day all-cause mortality compared to no mismatch (OR 16.493).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: